Skip to main content
. Author manuscript; available in PMC: 2010 Feb 18.
Published in final edited form as: J Immunol. 2009 Jun 1;182(11):7233–7243. doi: 10.4049/jimmunol.0801375

Table III.

Number of putative NF-AT, NF-κ, and GRE binding sites within proximal 2000 bp of the promoter region and the first intron, and the effect of FK506 and DEX

No. of Putative Binding Sites
Effect on FcεRI Signalb
Gene Name Ref. Seq.a NF-ATc NF-κBc GREd FK506 DEX
CCL2 NM_002982 9 (2) 4 (2) 4
CCL7 NM_006273 8 (3) 3 (1) 2
CXCL3 NM_002090 7 (4) 2 (0) 0
CXCL8 NM_000584 5 (1) 2 (1) 3
CCL1 NM_002981 3 (1) 5 (1) 7 No effect
CCL3 NM_002983 8 (2) 0 (0) 2
CCL4 NM_002984 7 (0) 6 (3) 4
CCL18 NM_002988 6 (3) 7 (1) 23
a

GenBank accession number of the reference sequences (www.ncbi.nlm.nih.gov/Genbank/index.html).

b

Effect of the drugs on the chemokine mRNA expression after stimulation via FcεRI.

c

Number of putative NF-AT and NF-κB binding sites within proximal 2000 bp (and within 500 bp) of the promoter region is shown.

d

Number of putative GRE binding sites in the first intron of the genes is shown.